Home/Filings/4/0001842952-22-000081
4//SEC Filing

Lehr Martin A. 4

Accession 0001842952-22-000081

CIK 0001842952other

Filed

Aug 21, 8:00 PM ET

Accepted

Aug 22, 4:04 PM ET

Size

5.2 KB

Accession

0001842952-22-000081

Insider Transaction Report

Form 4
Period: 2022-08-19
Lehr Martin A.
DirectorChief Executive Officer
Transactions
  • Purchase

    Common Stock

    2022-08-19$1.85/sh+13,000$24,064102,583 total
Holdings
  • Common Stock

    (indirect: By Trust)
    820,190

Issuer

Context Therapeutics Inc.

CIK 0001842952

Entity typeother

Related Parties

1
  • filerCIK 0001861989

Filing Metadata

Form type
4
Filed
Aug 21, 8:00 PM ET
Accepted
Aug 22, 4:04 PM ET
Size
5.2 KB